9 Meters Biopharma Inc
OTC:NMTRQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
9 Meters Biopharma Inc
OTC:NMTRQ
|
US |
|
P
|
Pearl Global Industries Ltd
BSE:532808
|
IN |
|
C
|
China Kings Resources Group Co Ltd
SSE:603505
|
CN |
|
L
|
Limelight Networks Inc
F:LNK
|
US |
|
United States Cellular Corp
NYSE:USM
|
US |
|
Nexity SA
PAR:NXI
|
FR |
|
Allegheny Technologies Inc
NYSE:ATI
|
US |
|
T
|
TerraVest Industries Inc
TSX:TVK
|
CA |
|
V
|
Vinafreight JSC
VN:VNF
|
VN |
|
QingDao Greensum Ecology Co Ltd
SZSE:300948
|
CN |
|
A
|
AJ Plast PCL
SET:AJ
|
TH |
|
B
|
Beijing Ultrapower Software Co Ltd
SZSE:300002
|
CN |
|
E
|
Exsim Hospitality Bhd
KLSE:EXSIMHB
|
MY |
|
Laxmi Cotspin Ltd
NSE:LAXMICOT
|
IN |
Balance Sheet
Balance Sheet Decomposition
9 Meters Biopharma Inc
9 Meters Biopharma Inc
Balance Sheet
9 Meters Biopharma Inc
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
0
|
6
|
5
|
38
|
47
|
13
|
|
| Cash |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
6
|
5
|
38
|
47
|
13
|
|
| Total Receivables |
1
|
4
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
4
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
3
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
3
|
20
|
|
| Total Current Assets |
2
|
6
|
2
|
4
|
1
|
6
|
5
|
39
|
50
|
33
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
6
+232%
|
5
-26%
|
6
+37%
|
1
-89%
|
6
+849%
|
5
-18%
|
39
+639%
|
50
+28%
|
33
-34%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
4
|
1
|
0
|
0
|
4
|
4
|
1
|
2
|
5
|
|
| Accrued Liabilities |
1
|
2
|
3
|
2
|
1
|
1
|
5
|
5
|
6
|
4
|
|
| Short-Term Debt |
1
|
5
|
4
|
0
|
1
|
5
|
3
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
|
| Other Current Liabilities |
0
|
1
|
2
|
2
|
0
|
0
|
3
|
0
|
0
|
2
|
|
| Total Current Liabilities |
2
|
11
|
10
|
4
|
3
|
10
|
15
|
7
|
8
|
31
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
11
+362%
|
10
-9%
|
4
-62%
|
3
-33%
|
10
+282%
|
15
+47%
|
7
-53%
|
9
+22%
|
31
+259%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
6
|
17
|
26
|
32
|
40
|
44
|
71
|
132
|
169
|
213
|
|
| Additional Paid In Capital |
6
|
12
|
20
|
35
|
38
|
40
|
61
|
164
|
210
|
215
|
|
| Total Equity |
1
N/A
|
5
-824%
|
6
-14%
|
2
N/A
|
2
N/A
|
4
-86%
|
10
-163%
|
32
N/A
|
42
+29%
|
2
-94%
|
|
| Total Liabilities & Equity |
2
N/A
|
6
+232%
|
5
-26%
|
6
+37%
|
1
-89%
|
6
+849%
|
5
-18%
|
39
+639%
|
50
+28%
|
33
-34%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
10
|
13
|
13
|
|